{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:53:00Z","timestamp":1791193980670,"version":"4.1.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroimaging Clinics of North America"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.nic.2006.06.004","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T15:10:36Z","timestamp":1168441836000},"page":"529-552","source":"Crossref","is-referenced-by-count":19,"title":["Opioid Imaging"],"prefix":"10.1016","volume":"16","author":[{"given":"Alexander","family":"Hammers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lingford-Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nic.2006.06.004_bib1","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1073\/pnas.70.8.2243","article-title":"Properties of opiate-receptor binding in rat brain","volume":"70","author":"Pert","year":"1973","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nic.2006.06.004_bib2","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1073\/pnas.70.7.1947","article-title":"Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate","volume":"70","author":"Simon","year":"1973","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nic.2006.06.004_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1600-0773.1973.tb01477.x","article-title":"Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat cerebral cortex","volume":"32","author":"Terenius","year":"1973","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"10.1016\/j.nic.2006.06.004_bib4","first-page":"517","article-title":"The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nic.2006.06.004_bib5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/267495a0","article-title":"Endogenous opioid peptides: multiple agonists and receptors","volume":"267","author":"Lord","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.nic.2006.06.004_bib6","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1476-5381.1981.tb08749.x","article-title":"Characterization of the kappa-subtype of the opiate receptor in the guinea-pig brain","volume":"73","author":"Kosterlitz","year":"1981","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.nic.2006.06.004_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0166-2236(97)01204-6","article-title":"Orphanin FQ\/nococeptin: a role in pain and analgesia, but so much more","volume":"21","author":"Darland","year":"1998","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.nic.2006.06.004_bib8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0031-6997(24)01502-3","article-title":"The molecular and behavioral pharmacology of the orphanin FQ\/nociceptin peptide and receptor family","volume":"53","author":"Mogil","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.nic.2006.06.004_bib9","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/bja\/66.3.370","article-title":"Opioid receptors and their ligands: natural and unnatural","volume":"66","author":"Pleuvry","year":"1991","journal-title":"Br J Anaesth"},{"issue":"Suppl 1","key":"10.1016\/j.nic.2006.06.004_bib10","first-page":"62","article-title":"TiPS receptor and ion channel nomenclature supplement 1999","volume":"19","author":"Alexander","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.nic.2006.06.004_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0074-7742(08)60666-2","article-title":"Endogenous opioid regulation of hippocampal function","volume":"39","author":"Simmons","year":"1996","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.nic.2006.06.004_bib12","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1073\/pnas.75.7.3503","article-title":"In vitro release of [5-methionine] enkephalin and [5-leucine] enkephalin from the rat globus pallidus","volume":"75","author":"Bayon","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nic.2006.06.004_bib13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0006-8993(89)91164-5","article-title":"Release of endogenous opioid peptides displaces [3H] diprenorphine binding in rat hippocampal slices","volume":"493","author":"Neumaier","year":"1989","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.nic.2006.06.004_bib14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1471-4159.1991.tb02132.x","article-title":"Focal stimulation of the mossy fibers releases endogenous dynorphins that bind kappa 1-opioid receptors in guinea pig hippocampus","volume":"57","author":"Wagner","year":"1991","journal-title":"J Neurochem"},{"key":"10.1016\/j.nic.2006.06.004_bib15","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1523\/JNEUROSCI.14-06-03736.1994","article-title":"Dynorphin opioids present in dentate granule cells may function as retrograde inhibitory neurotransmitters","volume":"14","author":"Drake","year":"1994","journal-title":"J Neurosci"},{"key":"10.1016\/j.nic.2006.06.004_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/299079a0","article-title":"Dynorphin (1\u20138) and dynorphin (1\u20139) are ligands for the kappa-subtype of opiate receptor","volume":"299","author":"Corbett","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.nic.2006.06.004_bib17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/1097-0282(2000)55:4<334::AID-BIP1006>3.0.CO;2-S","article-title":"Structure and regulation of opioid receptors","volume":"55","author":"Chaturvedi","year":"2000","journal-title":"Biopolymers"},{"key":"10.1016\/j.nic.2006.06.004_bib18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0301-0082(96)00045-7","article-title":"Dynorphin and epilepsy","volume":"50","author":"Simonato","year":"1996","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.nic.2006.06.004_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0006-8993(87)91141-3","article-title":"An in vitro autoradiographic analysis of mu and delta opioid binding in the hippocampal formation of kindled rats","volume":"412","author":"Crain","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.nic.2006.06.004_bib20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0006-8993(89)91397-8","article-title":"Administration of kainic acid and colchicine alters mu and lambda opiate binding in rat hippocampus","volume":"477","author":"Perry","year":"1989","journal-title":"Brain Res"},{"issue":"51","key":"10.1016\/j.nic.2006.06.004_bib21","doi-asserted-by":"crossref","first-page":"51630","DOI":"10.1074\/jbc.M307095200","article-title":"Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization","volume":"278","author":"Pfeiffer","year":"2003","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.nic.2006.06.004_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0306-4522(03)00135-0","article-title":"Ligand-induced mu opioid receptor endocytosis and recycling in enteric neurons","volume":"119","author":"Minnis","year":"2003","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.nic.2006.06.004_bib23","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1124\/jpet.103.063958","article-title":"Different regulation of human delta-opioid receptors by SNC-80 [(+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-meth oxybenzyl]-N,N-diethylbenzamide] and endogenous enkephalins","volume":"310","author":"Lecoq","year":"2004","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.nic.2006.06.004_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0024-3205(03)00250-9","article-title":"Internalization and recycling of human mu opioid receptors expressed in Sf9 insect cells","volume":"73","author":"Chen","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.nic.2006.06.004_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0006-8993(82)91150-7","article-title":"Opiate receptor binding sites in human brain","volume":"248","author":"Pfeiffer","year":"1982","journal-title":"Brain Res"},{"key":"10.1016\/j.nic.2006.06.004_bib26","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/BF02532374","article-title":"Laminar distribution of the multiple opioid receptors in the human cerebral cortex","volume":"21","author":"Hiller","year":"1996","journal-title":"Neurochem Res"},{"issue":"1\u20132","key":"10.1016\/j.nic.2006.06.004_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0006-8993(00)03302-3","article-title":"Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients","volume":"893","author":"Mathieu-Kia","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.nic.2006.06.004_bib28","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0306-4522(98)00251-6","article-title":"Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study","volume":"88","author":"Peckys","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.nic.2006.06.004_bib29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0361-9230(87)90080-3","article-title":"Autoradiographic distribution of multiple classes of opioid receptor binding sites in human forebrain","volume":"19","author":"Pilapil","year":"1987","journal-title":"Brain Res Bull"},{"issue":"3","key":"10.1016\/j.nic.2006.06.004_bib30","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00001756-199902250-00032","article-title":"Opioid receptors in the human cerebellum: evidence from [11C]diprenorphine PET, mRNA expression and autoradiography","volume":"10","author":"Schadrack","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.nic.2006.06.004_bib31","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/245447a0","article-title":"Regional distribution of opiate receptor binding in monkey and human brain","volume":"245","author":"Kuhar","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.nic.2006.06.004_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0304-3940(00)00943-5","article-title":"Autoradiographic distribution of mu-, delta- and kappa 1-opioid stimulated [35S]guanylyl-5\u2032-O-(gamma-thio)-triphosphate binding in human frontal cortex and cerebellum","volume":"283","author":"Platzer","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.nic.2006.06.004_bib33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0306-4522(99)00527-8","article-title":"Autoradiography of receptor-activated G-proteins in post mortem human brain","volume":"96","author":"Rodr\u00edguez-Puertas","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.nic.2006.06.004_bib34","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1176\/ajp.156.6.842","article-title":"Gender and age influences on human brain mu-opioid receptor binding measured by PET","volume":"156","author":"Zubieta","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.nic.2006.06.004_bib35","series-title":"Brain mapping: the methods","first-page":"191","article-title":"Imaging brain function with positron emission tomography","author":"Cherry","year":"1996"},{"key":"10.1016\/j.nic.2006.06.004_bib36","series-title":"PET. Grundlagen und Anwendungen der Positronen-Emissions-Tomographie","author":"Wienhard","year":"1989"},{"key":"10.1016\/j.nic.2006.06.004_bib37","series-title":"Positron emission tomography: basic science and clinical practice","first-page":"884","year":"2003"},{"issue":"4","key":"10.1016\/j.nic.2006.06.004_bib38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/nimg.1997.0303","article-title":"Parametric imaging of ligand-receptor binding in PET using a simplified reference region model","volume":"6","author":"Gunn","year":"1997","journal-title":"NeuroImage"},{"key":"10.1016\/j.nic.2006.06.004_bib39","doi-asserted-by":"crossref","first-page":"S665","DOI":"10.1038\/sj.jcbfm.9591524.0665","article-title":"Towards improved test-retest reliability in quantitative ligand PET: [11C]diprenorphine as an example","volume":"25","author":"Hammers","year":"2005","journal-title":"J Cereb Blood Flow Metab"},{"issue":"Pt 4","key":"10.1016\/j.nic.2006.06.004_bib40","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/brain\/awh441","article-title":"The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study","volume":"128","author":"von Spiczak","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.nic.2006.06.004_bib41","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/00004647-199709000-00003","article-title":"11C-diprenorphine binding in Huntington's disease: a comparison of region of interest analysis with statistical parametric mapping","volume":"17","author":"Weeks","year":"1997","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nic.2006.06.004_bib42","series-title":"Quantification of brain function: tracer kinetics and image analysis in brain PET","first-page":"289","article-title":"Parametric images of 11C-diprenorphine binding using spectral analysis of dynamic PET images acquired in 3D","author":"Tadokoro","year":"1993"},{"issue":"23","key":"10.1016\/j.nic.2006.06.004_bib43","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1088\/0031-9155\/48\/23\/002","article-title":"Rank-shaping regularization of exponential spectral analysis for application to functional parametric mapping","volume":"48","author":"Turkheimer","year":"2003","journal-title":"Phys Med Biol"},{"issue":"12","key":"10.1016\/j.nic.2006.06.004_bib44","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/00004647-200212000-00003","article-title":"Positron emission tomography compartmental models: a basis pursuit strategy for kinetic modeling","volume":"22","author":"Gunn","year":"2002","journal-title":"J Cereb Blood Flow Metab"},{"issue":"11","key":"10.1016\/j.nic.2006.06.004_bib45","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/00004647-199811000-00007","article-title":"Estimation of component and parameter distributions in spectral analysis","volume":"18","author":"Turkheimer","year":"1998","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"10.1016\/j.nic.2006.06.004_bib46","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.neuroimage.2003.10.015","article-title":"Bootstrapped DEPICT for error estimation in PET functional imaging","volume":"21","author":"Kukreja","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.nic.2006.06.004_bib47","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1212\/WNL.56.7.897","article-title":"Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy","volume":"56","author":"Hammers","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nic.2006.06.004_bib48","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.410320613","article-title":"Temporal lobectomy for uncontrolled seizures: the role of positron emission tomography","volume":"32","author":"Theodore","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nic.2006.06.004_bib49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1212\/WNL.43.1_Part_1.79","article-title":"Mesiobasal versus lateral temporal lobe epilepsy: metabolic differences shown in the temporal lobe shown by interictal 18F-FDG positron emission tomography","volume":"43","author":"Hajek","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.nic.2006.06.004_bib50","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/jcbfm.1990.128","article-title":"Quantifying interictal metabolic activity in human temporal lobe epilepsy","volume":"10","author":"Henry","year":"1990","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nic.2006.06.004_bib51","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/nimg.1997.0265","article-title":"MRI and PET coregistration: a cross validation of statistical parametric mapping and automated image registration","volume":"5","author":"Kiebel","year":"1997","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.nic.2006.06.004_bib52","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/WNL.49.3.764","article-title":"11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy","volume":"49","author":"Koepp","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.nic.2006.06.004_bib53","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1212\/WNL.57.7.1184","article-title":"In vivo hippocampal glucose metabolism in mesial temporal lobe epilepsy","volume":"57","author":"Knowlton","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nic.2006.06.004_bib54","series-title":"Quantitative functional brain imaging with positron emission tomography","first-page":"59","article-title":"Absolute PET quantification with correction for partial volume effects within cerebral structures","author":"Labb\u00e9","year":"1998"},{"key":"10.1016\/j.nic.2006.06.004_bib55","first-page":"904","article-title":"Correction for partial volume effects in PET: principle and validation","volume":"39","author":"Rousset","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nic.2006.06.004_bib56","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/00004647-200208000-00014","article-title":"Positron emission tomography partial volume correction: estimation and algorithms","volume":"22","author":"Aston","year":"2002","journal-title":"J Cereb Blood Flow Metab"},{"issue":"Pt 11","key":"10.1016\/j.nic.2006.06.004_bib57","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1093\/brain\/120.11.1961","article-title":"Cortical grey matter and benzodiazepine receptors in malformations of cortical development: a voxel-based comparison of structural and functional imaging data","volume":"120","author":"Richardson","year":"1997","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.nic.2006.06.004_bib58","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0014-2999(85)90379-6","article-title":"In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method","volume":"114","author":"Richards","year":"1985","journal-title":"Eur J Pharmacol"},{"issue":"Suppl","key":"10.1016\/j.nic.2006.06.004_bib59","first-page":"679","article-title":"Definition of a reference region for PET\/[11C]diprenorphine studies","volume":"23","author":"Asselin","year":"2003","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"10.1016\/j.nic.2006.06.004_bib60","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0014-2999(99)00460-4","article-title":"Differential binding properties of oripavines at cloned mu- and delta-opioid receptors","volume":"378","author":"Lee","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.nic.2006.06.004_bib61","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00004728-198503000-00001","article-title":"Imaging opiate receptors in the human brain by positron tomography","volume":"9","author":"Frost","year":"1985","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.nic.2006.06.004_bib62","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0165-0270(88)90184-7","article-title":"Regional cerebral opioid receptor studies with [11C]diprenorphine in normal volunteers","volume":"23","author":"Jones","year":"1988","journal-title":"J\u00a0Neurosci Methods"},{"issue":"7","key":"10.1016\/j.nic.2006.06.004_bib63","first-page":"1279","article-title":"6-O-(2-[18F]fluoroethyl)-6-O-desmethyldiprenorphine ([18F]DPN): synthesis, biologic evaluation, and comparison with [11C]DPN in humans","volume":"41","author":"Wester","year":"2000","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.nic.2006.06.004_bib64","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/jcbfm.1989.59","article-title":"Multicompartmental analysis of [11C]-carfentanil binding to opiate receptors in humans measured by positron emission tomography","volume":"9","author":"Frost","year":"1989","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nic.2006.06.004_bib65","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/nimg.1996.0066","article-title":"Simplified reference tissue model for PET receptor studies","volume":"4","author":"Lammertsma","year":"1996","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.nic.2006.06.004_bib66","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0969-8051(02)00411-0","article-title":"Quantification of brain mu-opioid receptors with [11C]carfentanil: reference-tissue methods","volume":"30","author":"Endres","year":"2003","journal-title":"Nucl Med Biol"},{"issue":"24","key":"10.1016\/j.nic.2006.06.004_bib67","doi-asserted-by":"crossref","first-page":"7720","DOI":"10.1021\/jm0507274","article-title":"Syntheses, biological evaluation, and molecular modeling of 18F-labeled 4-anilidopiperidines as mu-opioid receptor imaging agents","volume":"48","author":"Henriksen","year":"2005","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.nic.2006.06.004_bib68","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/(SICI)1098-2396(199609)24:1<19::AID-SYN3>3.0.CO;2-J","article-title":"Imaging of delta opioid receptors in human brain by N1\u2032-([11C]methyl)naltrindole and PET","volume":"24","author":"Madar","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.nic.2006.06.004_bib69","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ana.410410311","article-title":"Imaging of \u00f0- and \u03bc-opioid receptors in temporal lobe epilepsy by positron emission tomography","volume":"41","author":"Madar","year":"1997","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.nic.2006.06.004_bib70","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/00004647-199909000-00003","article-title":"Quantification of delta-opioid receptors in human brain with N1\u2032-([11C]methyl) naltrindole and positron emission tomography","volume":"19","author":"Smith","year":"1999","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"10.1016\/j.nic.2006.06.004_bib71","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0143-4179(88)90052-2","article-title":"A brief study of the selectivity of norbinaltorphimine, (-)-cyclofoxy, and (+)-cyclofoxy among opioid receptor subtypes in vitro","volume":"12","author":"Rothman","year":"1988","journal-title":"Neuropeptides"},{"key":"10.1016\/j.nic.2006.06.004_bib72","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0920-1211(92)90068-5","article-title":"PET imaging of opiate receptor binding in human epilepsy using [18F]cyclofoxy","volume":"13","author":"Theodore","year":"1992","journal-title":"Epilepsy Res"},{"issue":"2","key":"10.1016\/j.nic.2006.06.004_bib73","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0022-510X(96)05315-4","article-title":"Opiate receptor avidity and cerebral blood flow in Alzheimer's disease","volume":"148","author":"Cohen","year":"1997","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.nic.2006.06.004_bib74","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/1098-2396(200011)38:2<226::AID-SYN13>3.0.CO;2-#","article-title":"Opiate receptor avidity in the thalamus is sexually dimorphic in the elderly","volume":"38","author":"Cohen","year":"2000","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/j.nic.2006.06.004_bib75","first-page":"484","article-title":"11C\u2013GR103545, a radiotracer for imaging kappa-opioid receptors in vivo with PET: synthesis and evaluation in baboons","volume":"46","author":"Talbot","year":"2005","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.nic.2006.06.004_bib76","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0969-8051(01)00285-2","article-title":"[(11)C]-GR89696, a potent kappa opiate receptor radioligand; in vivo binding of the R and S enantiomers","volume":"29","author":"Ravert","year":"2002","journal-title":"Nucl Med Biol"},{"issue":"1","key":"10.1016\/j.nic.2006.06.004_bib77","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0304-3940(91)90362-W","article-title":"In vivo distribution of opioid receptors in man in relation to the cortical projections of the medial and lateral pain systems measured with positron emission tomography","volume":"126","author":"Jones","year":"1991","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.nic.2006.06.004_bib78","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.neuroimage.2005.10.033","article-title":"High opiate receptor binding potential in the human lateral pain system","volume":"30","author":"Baumgartner","year":"2006","journal-title":"Neuroimage"},{"issue":"5610","key":"10.1016\/j.nic.2006.06.004_bib79","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1126\/science.1078546","article-title":"COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor","volume":"299","author":"Zubieta","year":"2003","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.nic.2006.06.004_bib80","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neuroimage.2005.05.030","article-title":"COMT Val108\/158Met genotype affects the mu-opioid receptor system in the human brain: evidence from ligand-binding, G-protein activation and preproenkephalin mRNA expression","volume":"28","author":"Berthele","year":"2005","journal-title":"Neuroimage"},{"issue":"21","key":"10.1016\/j.nic.2006.06.004_bib81","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1523\/JNEUROSCI.5223-05.2006","article-title":"Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women","volume":"26","author":"Smith","year":"2006","journal-title":"J Neurosci"},{"issue":"11","key":"10.1016\/j.nic.2006.06.004_bib82","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/archpsyc.60.11.1145","article-title":"Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission","volume":"60","author":"Zubieta","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"10.1016\/j.nic.2006.06.004_bib83","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1073\/pnas.102174799","article-title":"mu-Opioid receptors and limbic responses to aversive emotional stimuli","volume":"99","author":"Liberzon","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.nic.2006.06.004_bib84","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejpain.2004.11.001","article-title":"Human brain mechanisms of pain perception and regulation in health and disease","volume":"9","author":"Apkarian","year":"2005","journal-title":"Eur J Pain"},{"issue":"5","key":"10.1016\/j.nic.2006.06.004_bib85","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejpain.2003.11.017","article-title":"Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [11C]diprenorphine binding and PET","volume":"8","author":"Jones","year":"2004","journal-title":"Eur J Pain"},{"issue":"3","key":"10.1016\/j.nic.2006.06.004_bib86","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pain.2003.08.014","article-title":"Central poststroke pain and reduced opioid receptor binding within pain processing circuitries: a [11C]diprenorphine PET study","volume":"108","author":"Willoch","year":"2004","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.nic.2006.06.004_bib87","first-page":"686","article-title":"Central pain after pontine infarction is associated with changes in opioid receptor binding: a PET study with 11C-diprenorphine","volume":"20","author":"Willoch","year":"1999","journal-title":"AJNR Am J Neuroradiol"},{"issue":"7","key":"10.1016\/j.nic.2006.06.004_bib88","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1212\/01.wnl.0000204225.15947.f8","article-title":"Opioidergic changes in the pineal gland and hypothalamus in cluster headache: a ligand PET study","volume":"66","author":"Sprenger","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nic.2006.06.004_bib89","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/10561","article-title":"Correlation between structural and functional changes in brain in an idiopathic headache syndrome","volume":"5","author":"May","year":"1999","journal-title":"Nat Med"},{"issue":"1\u20132","key":"10.1016\/j.nic.2006.06.004_bib90","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pain.2006.01.003","article-title":"Opioidergic activation in the medial pain system after heat pain","volume":"122","author":"Sprenger","year":"2006","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.nic.2006.06.004_bib91","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/rheumatology\/33.10.909","article-title":"Changes in central opioid receptor binding in relation to inflammation and pain in patients with rheumatoid arthritis","volume":"33","author":"Jones","year":"1994","journal-title":"Br J Rheumatol"},{"issue":"7","key":"10.1016\/j.nic.2006.06.004_bib92","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/00004647-199907000-00011","article-title":"Measurement of changes in opioid receptor binding in vivo during trigeminal neuralgic pain using [11C] diprenorphine and positron emission tomography","volume":"19","author":"Jones","year":"1999","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"10.1016\/j.nic.2006.06.004_bib93","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0304-3959(02)00266-X","article-title":"Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET)","volume":"99","author":"Bencherif","year":"2002","journal-title":"Pain"},{"issue":"5528","key":"10.1016\/j.nic.2006.06.004_bib94","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1126\/science.1060952","article-title":"Regional mu opioid receptor regulation of sensory and affective dimensions of pain","volume":"293","author":"Zubieta","year":"2001","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.nic.2006.06.004_bib95","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.1523\/JNEUROSCI.22-12-05100.2002","article-title":"\u03bc-opioid receptor-mediated antinociceptive responses differ in men and women","volume":"22","author":"Zubieta","year":"2002","journal-title":"J Neurosci"},{"issue":"34","key":"10.1016\/j.nic.2006.06.004_bib96","doi-asserted-by":"crossref","first-page":"7754","DOI":"10.1523\/JNEUROSCI.0439-05.2005","article-title":"Placebo effects mediated by endogenous opioid activity on mu-opioid receptors","volume":"25","author":"Zubieta","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.nic.2006.06.004_bib97","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0165-6147(88)90256-8","article-title":"Endogenous opioid peptides and epilepsy: quieting the seizing brain?","volume":"9","author":"Tortella","year":"1988","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.nic.2006.06.004_bib98","first-page":"145","article-title":"PET: opiate neuroreceptor mapping","volume":"83","author":"Koepp","year":"2000","journal-title":"Adv Neurol"},{"issue":"3","key":"10.1016\/j.nic.2006.06.004_bib99","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.nic.2004.04.012","article-title":"Flumazenil PET and other ligands for functional imaging","volume":"14","author":"Hammers","year":"2004","journal-title":"Neuroimaging Clin N Am"},{"key":"10.1016\/j.nic.2006.06.004_bib100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ana.410300103","article-title":"Quantification of mu and non-mu receptors in temporal lobe epilepsy using positron emission tomography","volume":"30","author":"Mayberg","year":"1991","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.nic.2006.06.004_bib101","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0920-1211(94)90004-3","article-title":"Quantification of opiate receptors in two patients with mesiobasal temporal lobe epilepsy, before and after selective amygdalohippocampectomy, using positron emission tomography","volume":"18","author":"Bartenstein","year":"1994","journal-title":"Epilepsy Res"},{"issue":"S7","key":"10.1016\/j.nic.2006.06.004_bib102","first-page":"100","article-title":"[11C]-diprenorphine PET in malformations of cortical development (MCD)","volume":"42","author":"Hammers","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.nic.2006.06.004_bib103","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/00004647-199607000-00016","article-title":"MR-based correction for brain PET measurements for heterogeneous gray matter radioactivity distribution","volume":"16","author":"Meltzer","year":"1996","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nic.2006.06.004_bib104","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ana.410230304","article-title":"Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy","volume":"23","author":"Frost","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nic.2006.06.004_bib105","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(97)09077-6","article-title":"Focal cortical release of endogenous opioids during reading-induced seizures","volume":"352","author":"Koepp","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.nic.2006.06.004_bib106","series-title":"Functional imaging in the epilepsies","first-page":"145","article-title":"PET: opiate neuroreceptor mapping","author":"Koepp","year":"2000"},{"key":"10.1016\/j.nic.2006.06.004_bib107","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0920-1211(94)90090-6","article-title":"Opiate receptors in idiopathic generalised epilepsy measured with 11C-diprenorphine and PET","volume":"19","author":"Prevett","year":"1994","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.nic.2006.06.004_bib108","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/jnnp.56.12.1295","article-title":"Investigation of the opioid system in absence seizures with positron emission tomography","volume":"56","author":"Bartenstein","year":"1993","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.nic.2006.06.004_bib109","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1602\/neurorx.1.2.243","article-title":"Neuroimaging in Parkinson's disease","volume":"1","author":"Brooks","year":"2004","journal-title":"NeuroRx"},{"issue":"Pt 4","key":"10.1016\/j.nic.2006.06.004_bib110","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/brain\/118.4.951","article-title":"Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome, a [11C]diprenorphine PET study","volume":"118","author":"Burn","year":"1995","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.nic.2006.06.004_bib111","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ana.410420508","article-title":"Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias","volume":"42","author":"Piccini","year":"1997","journal-title":"Ann Neurol"},{"issue":"4, Suppl 1","key":"10.1016\/j.nic.2006.06.004_bib112","first-page":"S154","article-title":"Neuroimaging of dyskinesia","volume":"47","author":"Brooks","year":"2000","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.nic.2006.06.004_bib113","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/mds.20238","article-title":"Opioid binding in DYT1 primary torsion dystonia: an 11C-diprenorphine PET study","volume":"19","author":"Whone","year":"2004","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.nic.2006.06.004_bib114","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/qjmed\/89.6.401","article-title":"Tourette's syndrome: a disorder of cingulate and orbitofrontal function?","volume":"89","author":"Weeks","year":"1996","journal-title":"QJM"},{"issue":"Suppl 2","key":"10.1016\/j.nic.2006.06.004_bib115","first-page":"S20","article-title":"Mu opiate receptor binding in amygdala in Alzheimer's disease: in vivo quantification by 11C carfentanil and PET","volume":"11","author":"Mueller-Gaertner","year":"1991","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9","key":"10.1016\/j.nic.2006.06.004_bib116","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1474-4422(04)00853-1","article-title":"PET imaging of amyloid in Alzheimer's disease","volume":"3","author":"Nordberg","year":"2004","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.nic.2006.06.004_bib117","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00259-002-0897-z","article-title":"PET imaging of human cardiac opioid receptors","volume":"29","author":"Villemagne","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.nic.2006.06.004_bib118","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrd897","article-title":"Pharmacotherapy of addictions","volume":"1","author":"Kreek","year":"2002","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"10.1016\/j.nic.2006.06.004_bib119","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/nm1196-1225","article-title":"Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving","volume":"2","author":"Zubieta","year":"1996","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.nic.2006.06.004_bib120","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.biopsych.2005.02.026","article-title":"Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving","volume":"57","author":"Gorelick","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.nic.2006.06.004_bib121","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1192\/bjp.182.2.97","article-title":"Neurobiology of addiction and implications for treatment","volume":"182","author":"Lingford-Hughes","year":"2003","journal-title":"Br J Psychiatry"},{"issue":"3","key":"10.1016\/j.nic.2006.06.004_bib122","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/026988110401800321","article-title":"Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology","volume":"18","author":"Lingford-Hughes","year":"2004","journal-title":"J\u00a0Psychopharmacol"},{"issue":"1","key":"10.1016\/j.nic.2006.06.004_bib123","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archpsyc.62.1.57","article-title":"Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil","volume":"62","author":"Heinz","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/j.nic.2006.06.004_bib124","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0893-133X(00)00110-X","article-title":"Buprenorphine-induced changes in mu-opioid receptor availability in male heroin-dependent volunteers: a preliminary study","volume":"23","author":"Zubieta","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nic.2006.06.004_bib125","unstructured":"Williams TM, Daglish MRC, Lingford-Hughes AR, et\u00a0al. Increased availability of opioid receptors in early abstinence from opioid dependence: an [11C]diprenorphine PET study. Submitted."},{"issue":"7","key":"10.1016\/j.nic.2006.06.004_bib126","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/00006231-200107000-00016","article-title":"Probing targets for antipsychotic drug action with PET and SPET receptor imaging","volume":"22","author":"Pilowsky","year":"2001","journal-title":"Nucl Med Commun"},{"issue":"3","key":"10.1016\/j.nic.2006.06.004_bib127","first-page":"1070","article-title":"Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term,\u00a0methadone-treated former heroin addicts","volume":"295","author":"Kling","year":"2000","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.nic.2006.06.004_bib128","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1124\/jpet.104.072686","article-title":"Using [11C]diprenorphine to image opioid receptor occupancy by methadone in opioid addiction: clinical and preclinical studies","volume":"312","author":"Melichar","year":"2005","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.nic.2006.06.004_bib129","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/1355621031000069891","article-title":"Using saccadic eye movements as objective measures of tolerance in methadone dependent individuals during the hydromorphone challenge test","volume":"8","author":"Melichar","year":"2003","journal-title":"Addict Biol"},{"issue":"3","key":"10.1016\/j.nic.2006.06.004_bib130","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0196-9781(96)00002-2","article-title":"Downregulation of mu-opioid binding sites following chronic administration of neuropeptide FF (NPFF) and morphine","volume":"17","author":"Goodman","year":"1996","journal-title":"Peptides"},{"key":"10.1016\/j.nic.2006.06.004_bib131","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1749-6632.1995.tb17493.x","article-title":"Opiate receptor changes after chronic exposure to agonists and antagonists","volume":"757","author":"Zadina","year":"1995","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"10.1016\/j.nic.2006.06.004_bib132","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.npp.1300251","article-title":"Effects of buprenorphine maintenance dose on\u00a0mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers","volume":"28","author":"Greenwald","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nic.2006.06.004_bib133","first-page":"192","article-title":"Enhancement of MR images using registration for signal averaging","volume":"18","author":"Holmes","year":"1998","journal-title":"J Comput Assist Tomogr"},{"issue":"4","key":"10.1016\/j.nic.2006.06.004_bib134","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1162\/089892904323057399","article-title":"An FMRI study of syntactic adaptation","volume":"16","author":"Noppeney","year":"2004","journal-title":"J Cogn Neurosci"}],"container-title":["Neuroimaging Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052514906000712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052514906000712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T22:10:35Z","timestamp":1736719835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052514906000712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":134,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S1052514906000712"],"URL":"https:\/\/doi.org\/10.1016\/j.nic.2006.06.004","relation":{},"ISSN":["1052-5149"],"issn-type":[{"value":"1052-5149","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}